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Abstract
Background: This study aimed to assess the associations of serum uric acid (SUA) levels and hyperuricemia with
cardiometabolic risk factors in a Chinese community-dwelling population.
Methods: A large cohort of 4706 residents was enrolled in this study. Physical examinations and laboratory tests
were performed following a standardized protocol. Multiple linear and logistic regression analyses were conducted
with adjustment of cardiometabolic risk factors including age, sex, body mass index (BMI), blood pressure (BP),
triglyceride (TG), high-density lipoprotein-cholesterol (HDL-c), low-density lipoprotein-cholesterol (LDL-c) and
fasting blood glucose (FBG) levels using SPSS version 17 software.
Results: The prevalence of hyperuricemia was 7.6 %. There were significant differences in age, BMI, BP, TG,
HDL-c, LDL-c and FBG levels and the proportion of men between participants with and without hyperuricemia.
Multiple linear regression analysis showed that SUA levels were positively associated with age, sex, BMI, BP, TG and
LDL-c levels, but negatively associated with HDL-c and FBG levels. Multiple logistic regression analysis showed that per
unit increase in age was associated with a 1.014 times higher odds of the presence of hyperuricemia. Men had a 1.858
times higher odds of the presence of hyperuricemia compared with women. Per unit increases in BMI, BP,
TG and LDL-c levels were associated with 1.103, 1.016, 1.173 and 1.200 times higher odds of the presence of
hyperuricemia, respectively. Per unit increases in HDL-c and FBG levels were associated with 0.616 and 0.900
times lower odds of the presence of hyperuricemia, respectively.
Conclusions: In a Chinese community-dwelling population, age, sex, BMI, BP, TG, HDL-c, LDL-c and FBG levels
are cardiometabolic risk factors that are significantly associated with SUA levels, as well as the presence of
hyperuricemia.
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Background
Serum uric acid (SUA) is an end product of purine ca-
tabolism in humans and higher primates. In parallel with
rapid development of cardiometabolic risk factors, in-
cluding aging, obesity, high blood pressure (BP), lipids
and glucose, the prevalence of hyperuricemia is also
rising in developing and developed countries [1, 2]. Ele-
vated levels of SUA are associated with increased cardio-
vascular morbidity and mortality in subjects who already
have cardiometabolic risk factors [3–5]. The role of
SUA in elevation of cardiovascular morbidity and
mortality remains unclear. Further studies on cardio-
metabolic risk factors associated with SUA levels
might uncover previously unrecognized pathophysiological
mechanisms between SUA levels and cardiovascular mor-
bidity and mortality [6]. Recently, SUA levels were reported
to be related to cardiometabolic risk factors including
advanced age, obesity, high blood pressure, lipids
and glucose [7, 8]. However, the specific associations
between SUA levels and cardiometabolic risk factors
remain undefined. Moreover, there is evidence that
hyperuricemia is not uncommon in China. However,
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studies in Chinese community-dwelling population
on the associations between SUA levels and cardio-
metabolic risk factors are scarce [6]. Therefore, we
conducted a comprehensive study involving a large
cohort of Chinese community-dwelling population to
assess the potential associations of SUA levels and
hyperuricemia with cardiometabolic risk factors,.
Methods
Study population
This study enrolled a large cohort of 4706 community-
dwelling residents in the Beijing area. Participants were
consecutively referred by physicians in the local health
service center for a medical examination between May
2007 and July 2009. Recruited individuals were Han in
origin and older than 18 years. Community-dwelling
residents were defined as residents who have lived in the
communities for at least 6 months. A stratified cluster
sampling design was used in this survey. In the first
stage of sampling, three districts (Fengtai, Shijingshan,
and Daxing) were selected from 18 districts in Beijing.
In the second stage of sampling, four communities were
selected from these districts. In the third stage of sam-
pling, participants were selected from these communi-
ties to represent the overall Beijing population. The
study protocol was approved by the Ethics Committee
of Chinese People’s Liberation Army General Hospital
(Beijing, China). Each participant provided written in-
formed consent to be included in the study.
Physical examinations
Physical examinations were performed following a stan-
dardized protocol. Anthropometrics were measured in the
clinic, with participants wearing light clothing and no
shoes. Height was measured in centimeters using a wall-
mounted measuring tape, and weight was measured in
kilograms using a digital scale. Body mass index (BMI)
was calculated as weight (kg) divided by height squared
(m2). BP was measured by well-trained personnel on the
right arm of the seated participant, after at least 5 min of
rest, with a mercury sphygmomanometer (Yuwell Medical
Equipment & Supply Co., Ltd., Jiangsu, China) and an
appropriately-sized cuff. Two sequential BP measurements
were obtained, and the average was used for analysis. Pulse
pressure (PP) was the difference between systolic BP and
diastolic BP (DBP).
Biochemical measurements
Venous blood specimens were routinely collected by
venipuncture between 8 am and 10 am in overnight
fasting subjects after they had been in the supine pos-
ition for 5 min. After blood was drawn, specimens were
routinely stored and delivered to the central laboratory
in the Department of Biochemistry, Chinese People’s
Liberation Army General Hospital, on the same date.
Fasting blood glucose (FBG), triglyceride (TG), high-
density lipoprotein-cholesterol (HDL-c), low-density
lipoprotein-cholesterol (LDL-c) and SUA levels were
measured directly by a qualified technician blinded to
clinical data using enzymatic assays (Roche Products
Ltd., Basel, Switzerland) on a full automatic biochem-
ical autoanalyzer (COBAS c6000; Roche Products Ltd.).
The criteria used to define hyperuricemia were SUV
levels greater than 360 μmol/L and 420 μmol/L in
women and men, respectively [9].
Statistical analysis
All continuous variables are shown as mean and stand-
ard deviation (SD, normal distribution) or median and
interquartile range (non-normal distribution). Categorical
variables are shown as number and proportion. Continuous
variables were compared using the Student’s t-test (normal
distribution) or Mann–Whitney U test (non-normal
distribution). Comparison of categorical variables was
conducted by the chi-square test. To evaluate the as-
sociations between SUA levels and cardiometabolic
risk factors as continuous variables, Pearson’s correl-
ation or Spearman’s correlation analysis was used in
univariate analysis, and multiple linear regression ana-
lysis (stepwise) was also conducted with adjustment
of cardiometabolic risk factors including age, sex,
BMI, BP, TG, HDL-c, LDL-c and FBG levels; SUA
levels as skewed variable were logarithmically trans-
formed to improve normality prior to this analysis. In
addition, to better assess cardiometabolic risk factors
associated with hyperuricemia, multiple logistic re-
gression analysis (backward stepwise) was conducted
after adjusting for cardiometabolic risk factors includ-
ing age, sex, BMI, BP, TG, HDL-c, LDL-c and FBG
levels. Stepwise regression analyses were based on a statis-
tical significance test criterion (p values). All analyses were
carried out using SPSS version 17 software (SPSS Inc.,
Chicago, IL, USA) and the level of statistical significance
was always set at p < 0.05.
Results
General characteristics
For all of the 4706 individuals, the median age was
51 years (range, 18–96 years), and 2283 (48.5 %) were
men. The prevalence rate of hyperuricemia, hyperten-
sion, diabetes and a history of cardiovascular disease was
7.6 % (359 participants), 39.6 % (1864 participants),
10.7 % (505 participants) and 11.6 % (547 participants),
respectively. There were significant differences in age,
BMI, PP, DBP, TG, HDL-c, LDL-c and FBG levels and
the proportion of men between participants with and
without hyperuricemia (all p < 0.05; Table 1).
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Cardiometabolic risk factors associated with SUA levels
Simple correlation analysis showed that SUA levels
were positively related to age, sex, BMI, PP, DBP, TG,
LDL-c and FBG levels, but negatively related to HDL-
c levels (all p < 0.05; Table 2). Multiple linear regres-
sion analysis showed that SUA levels were positively
associated with age, sex, BMI, PP, TG, and LDL-c
levels, but negatively associated with HDL-c and FBG
levels (all p < 0.05; Table 2).
Cardiometabolic risk factors associated with
hyperuricemia
Multiple logistic regression analysis (Table 3) showed
that per unit increase in age was associated with a
1.014 times higher odds of the presence of hyperurice-
mia (p < 0.05). Men had a 1.858 times higher odds of
the presence of hyperuricemia compared with women
(p < 0.05). Per unit increases in BMI, PP, TG and LDL-c
levels were associated with 1.103, 1.016, 1.173 and
1.200 times higher odds of the presence of hyperurice-
mia, respectively (all p < 0.05). Per unit increases in
HDL-c and FBG levels were associated with 0.616 and
0.900 times lower odds of the presence of hyperurice-
mia, respectively (all p < 0.05).
Discussion
Previous studies in the United States have shown that, in
men, SUA levels increase between 10 and 16 years of
age and reach a peak at approximately 20 years, whereas,
in women, SUA levels increase at approximately 50 years
[10]. In a previous univariate analysis on Chinese people,
SUA levels of male participants reached a peak between
13 and 18 years of age and slightly decreased after
18 years, whereas SUA levels of female participants were
stable before 18 years and slightly decreased between 19
and 44 years, and then increased in the mid to older age
Table 1 Characteristics of all individuals divided by the presence of hyperuricemia or not
Characteristics All participants (n = 4706) Hyperuricemia (n = 359) Control (n = 4347) P-value
Age (year)a 51 (39–62) 56 (42–69) 51 (39–61) <0.001
Men (%)b 2283 (48.5) 217 (60.4) 2066 (47.5) <0.001
BMI (kg/m2)a 25.51 (23.15–28.06) 27.34 (24.98–29.74) 25.35 (23.03–27.92) <0.001
PP (mmHg)a 48 (40–58) 53 (43–64) 48 (40–58) <0.001
DBP (mmHg)a 79 (70–84) 80 (72–86) 78 (70–84) <0.001
TG (mmol/L)a 1.36 (0.95–2.00) 1.93 (1.40–2.91) 1.33 (0.93–1.91) <0.001
HDL-c (mmol/L)a 1.38 (1.17–1.62) 1.26 (1.06–1.48) 1.39 (1.18–1.63) <0.001
LDL-c (mmol/L)a 2.75 (2.27–3.26) 2.96 (2.46–3.43) 2.73 (2.25–3.25) <0.001
FBG (mmol/L)a 4.98 (4.64–5.41) 5.08 (4.68–5.54) 4.97 (4.63–5.39) 0.004
BMI body mass index, PP pulse pressure, DBP diastolic blood pressure, TG triglyceride, HDL-c high-density lipoprotein-cholesterol, LDL-c low-density lipoprotein-
cholesterol, FBG fasting blood glucose
aMedian (interquartile range)
bnumber (proportion)
Table 2 Cardiometabolic risk factors associated with serum uric acid levels in simple correlation and multiple linear regression
analyses
Variables Simple correlation Multiple linear regression
Correlation coefficient P-value β-value P-value
Age (year) 0.066a <0.001 0.071a <0.001
Men/women 0.477a <0.001 0.458a <0.001
BMI (kg/m2) 0.233a <0.001 0.166a <0.001
PP (mmHg) 0.117a <0.001 0.041a 0.003
DBP (mmHg) 0.139a <0.001 −0.022 0.087
TG (mmol/L) 0.328a <0.001 0.148a <0.001
HDL-c (mmol/L) −0.291b <0.001 −0.071b <0.001
LDL-c (mmol/L) 0.092a <0.001 0.072a <0.001
FBG (mmol/L) 0.046a 0.002 −0.115b <0.001
BMI body mass index, PP pulse pressure, DBP diastolic blood pressure, TG triglyceride, HDL-c high-density lipoprotein-cholesterol, LDL-c low-density
lipoprotein-cholesterol, FBG fasting blood glucose
aPositive
bnegative
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groups (≥45 years) [1]. Another Chinese study showed that,
in women, age was highly significantly correlated with SUA
levels in univariate and multivariate analyses, whereas, in
men, a weak correlation was found only in univariate ana-
lysis [6]. The current study showed that there was a positive
association between age and SUA levels, and an increase in
age was significantly associated with an increased odds of
hyperuricemia. In addition, men had a higher odds of hy-
peruricemia compared with women. Sex differences in
SUA levels might be induced by urate-depressing action of
estrogens [10].
A report from 8000 men of Japanese ancestry liv-
ing in Hawaii proposed that weight was the most
important correlate with SUA levels [11]. In Melane-
sians and Asian Indians, BMI was significantly corre-
lated with SUA levels [12]. Another multivariate
analysis on Chinese people also confirmed that BMI
was an important factor associated with hyperurice-
mia [1]. Consistent with these studies, our data
showed that there was a significant association be-
tween BMI and SUA levels, and an increase in BMI
was significantly associated with an increased odds
of hyperuricemia.
Using univariate and multivariate analyses, a relation-
ship between BP and SUA levels has been demonstrated
in several studies [13, 14]. However, in Okada et al’s
study, BP was not selected as a variable related to SUA
levels in multiple linear regression analysis [15]. This
finding from one previous Chinese study suggested that
the relation of SUA levels with BP might be explained by
the obvious correlation of BMI with both BP and SUA
levels. However, the current study showed that BP was
positively correlated with SUA levels. Moreover, an in-
crease in BP was significantly associated with an in-
creased odds of hyperuricemia.
In healthy young black and white adults aged 18–30 years
from the Coronary Artery Risk Development in Young
Adults study, 10-year changes in serum TG levels were
strictly related to changes in SUA levels [16]. In the
Japanese-American population in Hawaii and among
Japanese male office workers in Osaka, a positive asso-
ciation was shown between SUA and TG levels [11, 17].
SUA levels were also found to be inversely correlated
with HDL-c levels in adolescents and adults [18]. How-
ever, a previous investigation also highlighted that an
unclear relationship existed between SUA levels and
lipid metabolism [19]. Positive associations of SUA
levels with TG and LDL-c levels as well as a negative
association between SUA and HDL-c levels were sig-
nificant in the Chinese cohorts in the current study.
Moreover, we found that an increase in TG and LDL-c
levels and a decrease in HDL-c levels were significantly
associated with an increased odds of hyperuricemia.
In a survey of middle-aged men from British towns,
SUA levels increased with increasing FBG levels up to
approximately 8.0 mmol/L; at higher levels of FBG, SUA
levels decreased [20]. Joint research from Sweden and
United Kingdom showed an increase in SUA levels with
increasing FBG levels up to 7.0 mmol/L in men and
9.0 mmol/L in women, and thereafter increasing FBG
levels were accompanied by a significant decrease in SUA
levels [21]. The current study confirmed negative associa-
tions of FBG levels with SUA levels and hyperuricemia.
Our study has a limitation. Because of the cross-sectional
design, our results could not suggest any cause-effect
mechanism linking the presence of increased SUA levels to
cardiometabolic risk factors.
Conclusions
This study shows that in a Chinese community-dwelling
population, age, sex, BMI, BP, TG, HDL-c, LDL-c and
FBG levels are cardiometabolic risk factors that are sig-
nificantly associated not only with SUA levels, as well as
with the presence of hyperuricemia.
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Table 3 Cardiometabolic risk factors associated with
hyperuricemia in multiple logistic regression analysis
Variables OR 95 % CI P-value
Age (year) 1.014a 1.005–1.023 0.002
Men/women 1.858a 1.464–2.359 <0.001
BMI (kg/m2) 1.103a 1.069–1.137 <0.001
PP (mmHg) 1.016a 1.008–1.024 <0.001
DBP (mmHg) 0.999 0.989–1.010 0.866
TG (mmol/L) 1.173a 1.103–1.247 <0.001
HDL-c (mmol/L) 0.616b 0.415–0.914 0.016
LDL-c (mmol/L) 1.200a 1.036–1.390 0.015
FBG (mmol/L) 0.900b 0.819–0.989 0.028
OR odd ratio, CI confidence interval, BMI body mass index, PP pulse pressure,
DBP diastolic blood pressure, TG triglyceride, HDL-c high-density
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